Vitamin E exhibits bone anabolic actions in normal male rats

被引:0
作者
Ahmad Nazrun Shuid
Zulfadli Mehat
Norazlina Mohamed
Norliza Muhammad
Ima Nirwana Soelaiman
机构
[1] Universiti Kebangsaan Malaysia,Department of Pharmacology, Faculty of Medicine UKM
来源
Journal of Bone and Mineral Metabolism | 2010年 / 28卷
关键词
Bone anabolic agent; Vitamin E; Tocotrienol; Bone histomorphometry; Bone biomechanical test;
D O I
暂无
中图分类号
学科分类号
摘要
Recently, vitamin E has been found to promote the bone structure of nicotine-treated rats well above their baseline values, thus suggesting that vitamin E may have some anabolic action. A bone anabolic agent acts by improving the bone structure leading to stronger bone. To assess the possible anabolic action vitamin E on bone, we supplemented α-tocopherol (ATF) or γ-tocotrienol (GTT) at 60 mg/kg or vehicle [normal control (NC) group] for 4 months to normal male rats and measured their bone structure and biomechanical properties. Histomorphometric analysis revealed that vitamin E-supplemented rats have better trabecular volume, thickness, number, and separation than rats receiving vehicle only. For the first time we reported that GTT improves all the parameters of bone biomechanical strength, while ATF only improved some of the parameters compared to the NC group. Vitamin E supplementation, especially with the gamma isomer, improves bone structure, which contributed to stronger bone. Therefore, vitamin E has the potential to be used as an anabolic agent to treat osteoporosis or as bone supplements for young adults to prevent osteoporosis in later years.
引用
收藏
页码:149 / 156
页数:7
相关论文
共 192 条
[1]  
Canalis E(2007)Mechanisms of anabolic therapies for osteoporosis N Engl J Med 357 905-916
[2]  
Giustina A(2001)Strontium ranelate inhibits bone resorption whilst maintaining bone formation in alveolar bone in monkeys Bone 29 176-179
[3]  
Bilezikian JP(2002)Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice Metabolism 51 906-911
[4]  
Buehler J(2004)Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats J Bone Miner Res 19 2012-2020
[5]  
Chappuis P(2005)Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling J Bone Miner Res 20 177-184
[6]  
Saffar JL(2009)Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in Sprague–Dawley male rats after nicotine cessation Calcif Tissue Int 84 65-74
[7]  
Foos E(2000)Vitamin E: non-antioxidant roles Prog Lipid Res 39 231-255
[8]  
Vignery A(2002)Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans Atherosclerosis 161 199-207
[9]  
Delannoy P(1991)Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats Am J Clin Nutr 53 1076-1081
[10]  
Bazot D(1998)Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status Lipids 33 461-469